FDA stability – Page 21

Stability Data Gaps Caused by Poor Batch Selection Strategy

Addressing Stability Study Design Errors Due to Inadequate Batch Selection Strategies Stability study design errors can severely impact the validity of pharmaceutical product shelf-life assessments, leading to compliance issues, financial…

How to Prepare Stability Summaries for Annual Product Quality Review

Effective Preparation of Stability Summaries for Annual Product Quality Review Stability summaries are critical components of the Annual Product Quality Review (APQR) for pharmaceuticals, ensuring products meet regulatory expectations throughout…

How to Build Stability Studies That Survive FDA and MHRA Review

Resolving Common Stability Study Design Errors for Regulatory Compliance Stability studies are critical in pharmaceutical development, ensuring that products maintain their intended safety and efficacy throughout their shelf life. However,…

Regulatory Expectations for Ongoing Stability Programs in Commercial Manufacturing

Understanding Regulatory Guidelines for Ongoing Stability Programs in Pharmaceutical Manufacturing Many pharmaceutical manufacturers face challenges in meeting the rigorous regulatory expectations for stability studies as part of their ongoing quality…

Stability Protocol Approval Errors That Delay Regulatory Submission

Resolving Stability Protocol Approval Errors to Expedite Regulatory Submissions In the realm of pharmaceutical manufacturing, stability study design errors can significantly hamper a company’s ability to achieve timely regulatory approval.…

How to Manage Stability Commitments After Product Approval

Implementing Compliance for Stability Commitments Post-Product Approval In the dynamic environment of pharmaceutical manufacturing, adherence to regulatory expectations for stability studies is critical not only during development but also post-approval.…

Why Sample Orientation Matters in Photostability and Long-Term Storage

Understanding the Importance of Sample Orientation in Photostability and Long-Term Storage In the realm of pharmaceutical stability studies, sample orientation is often underestimated, leading to stability study design errors that…

Stability Study Requirements for New Strengths and Additional Pack Sizes

Understanding Stability Study Requirements for New Strengths and Pack Sizes Pharmaceutical manufacturers often face challenges when introducing new strengths or additional pack sizes for established products. These changes necessitate thorough…

Stability Design Failures in Accelerated Studies at 40°C/75% RH

Addressing Stability Study Design Errors in Accelerated Studies at 40°C/75% RH Stability studies serve as critical assessments of pharmaceutical product integrity over time. Errors in study design, especially during accelerated…

How to Defend Stability Extrapolation During Regulatory Review

Defending Stability Extrapolation During Regulatory Review As regulatory bodies emphasize robust stability studies, pharmaceutical professionals face challenges related to data extrapolation in stability assessments. Being well-prepared to defend your stability…

How Packaging Configuration Errors Distort Stability Conclusions

Understanding and Addressing Packaging Configuration Errors in Stability Studies In pharmaceutical manufacturing, ensuring the stability of products throughout their shelf life is of paramount importance. However, packaging configuration errors can…

Regulatory Expectations for Shelf-Life Assignment and Expiry Dating

Understanding Regulatory Expectations for Stability Studies and Expiry Dating Pharmaceutical manufacturers often face challenges in ensuring their products meet the regulatory expectations for stability studies and expiry dating. Non-compliance or…